{
    "code": "60001055",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001055",
    "time": "2020-05-22 03:16:29",
    "許可證字號": "衛部菌疫輸字第001055號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/07\/26",
    "發證日期": "106\/07\/26",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000105509",
    "中文品名": "諾和第八因子注射劑 250 IU",
    "英文品名": "NovoEight 250 IU",
    "適應症": "1.控制及預防成人及兒童A型血友病患者之出血事件。\r\n2.成人及兒童A型血友病患者手術前中後之處置。\r\n3.作為例行預防，預防或降低成人及兒童A 型血友病患者之出血事件發生率。\r\n\r\n本品不適用於治療von Willebrand disease。",
    "劑型": "243凍晶注射劑",
    "包裝": "玻璃小瓶附注射針筒裝溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品",
    "監視期限": "",
    "主成分略述": "Turoctocog alfa",
    "限制項目": "02輸　入 1L監視中新藥 51免除銜接性臨床試驗",
    "申請商名稱": "1426801100  台灣諾和諾德藥品股份有限公司",
    "申請商地址": "台北市大安區敦化南路2段207號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDK0034000  NOVO NORDISK A\/S",
            "製造廠廠址": "HAGEDORNSVEJ 1, DK 2820 GENTOFTE, DENMARK",
            "製造廠公司地址": "",
            "製造廠國別": "DENMARK",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDE0292000  VETTER PHARMA-FERTIGUNG GMBH &amp; CO. KG",
            "製造廠廠址": "EISENBAHNSTRASSE 2-4, 88085 LANGENARGEN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "注射針筒裝溶劑製造廠"
        },
        {
            "製造廠名稱": "FDK0042000  NOVO NORDISK A\/S",
            "製造廠廠址": "HALLAS ALLE, DK-4400 KALUNDBORG, DENMARK",
            "製造廠公司地址": "",
            "製造廠國別": "DENMARK",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FDK0053000  Novo Nordisk A\/S",
            "製造廠廠址": "Brennum Park DK-3400 Hillerod, Denmark",
            "製造廠公司地址": "",
            "製造廠國別": "DENMARK",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "FUS1151000  NOVO NORDISK US BIO PRODUCTION, INC.",
            "製造廠廠址": "9 TECHNOLOGY DRIVE, WEST LEBANON, NEW HAMPSHIRE, 03784, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012103300",
            "成分名稱": "Turoctocog alfa",
            "含量描述": "",
            "含量": "62.5000000000",
            "單位": "IU"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "N8_250-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "NovoEight 250IU+500IU+1000IU-108-12-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=004&Type=9"
        },
        {
            "title": "NovoEight 250IU Label (8-9063-10-201-1)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=005&Type=8"
        },
        {
            "title": "NovoEight 250IU Carton (8-9063-10-301-1)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=004&Type=8"
        },
        {
            "title": "solvent label-106-08-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=003&Type=8"
        },
        {
            "title": "Label 250 IU-106-08-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=002&Type=8"
        },
        {
            "title": "Carton 250 IU-106-08-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001055&Seq=001&Type=8"
        }
    ]
}